You are about to leave the Clinical Value website now.
Cancel
Continue
Cervical Cancer
No woman left behind: Increasing access to testing for cervical cancer elimination
Read ArticleNo woman left behind: Increasing access to testing for cervical…
Cervical cancer has a high disease burden in APAC, with 50% of global cases and 60% of global deaths occurring in APAC. Almost all (99%) cervical cancer cases are linked to infection with high risk human papillomavirus, which is easily preventable through vaccination, advances in screening, and appropriate treatment. However, barriers still exist that prevent some women from being screened for cervical cancer